Global and Chinese burden of non-alcoholic fatty liver disease in chronic liver disease: Findings from the Global Burden of Disease Study 2021
The burden of CLD and NAFLD remains substantial globally and within China in terms of high prevalence and incidence. As such, this underscores the need for targeted prevention and treatment strategies. These findings emphasize the importance of continued surveillance and research to mitigate the growing impact of liver diseases on global and Chinese health systems.
Authors
- Wei Ji (ORCID: https://orcid.org/0000-0002-9730-1015)
- Jidong Jia (ORCID: https://orcid.org/0000-0002-4673-8890)
- Yuanyuan Kong (ORCID: https://orcid.org/0000-0002-2586-1443)
- Xinyu Zhao (ORCID: https://orcid.org/0000-0003-4123-3030)
- Tingting Xiao (ORCID: https://orcid.org/0000-0001-7311-4496)
- Dongxu Wang (ORCID: https://orcid.org/0000-0001-9371-195X)
- Jingjie Zhao (ORCID: https://orcid.org/0000-0002-1582-2053)
- Hong You (ORCID: https://orcid.org/0000-0001-9409-1158)
- Dong Xu (ORCID: https://orcid.org/0000-0003-2243-1883)
- Cheng Huang (ORCID: https://orcid.org/0009-0006-9407-1097)
- Zhengzhao Lu
Institutions
- Capital Medical University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2025-06-20
- DOI
- https://doi.org/10.1097/cm9.0000000000003726
- Citations
- 8
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 10.83